Jove
Visualize
Contact Us

Related Experiment Videos

Analyzing randomized dose finding studies with a primary and a secondary endpoint.

Ludwig A Hothorn1, Gernot Wassmer

  • 1Bioinformatics Unit, University of Hannover, Hannover, Germany. hothorn@bioinf.uni-hannover.de

Journal of Biopharmaceutical Statistics
|May 6, 2003
PubMed
Summary

This study identifies the minimum effective dose for primary and secondary outcomes using stepwise testing. This method controls the overall Type I error rate for hypothesis testing in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plant Kelch phosphatases are Ser/Thr phosphatases involved in cell cycle regulation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A Note on "A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design".

Statistics in medicine·2026
Same author

The role of statistical power in context: implications for regulatory practices.

Integrated environmental assessment and management·2026
Same author

Multiple Contrast Tests for Count Data: Small Sample Approximations and Their Limitations.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Clinical trials with interim analyses: standardizing terminology to increase clarity.

Trials·2025
Same author

Analysis of Covariance in General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity.

Statistics in medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Determining the minimum effective dose is crucial for drug development.
  • Controlling experimentwise Type I error is essential for valid statistical inference.

Purpose of the Study:

  • To describe a method for identifying the minimum effective dose for primary and secondary endpoints.
  • To utilize stepwise testing procedures for hypothesis evaluation.

Main Methods:

  • The study describes a procedure for dose identification based on an a priori importance ordering of endpoints.
  • Stepwise testing procedures are employed to conditionally test elementary hypotheses.
  • The experimentwise Type I error rate is controlled at level alpha.

Related Experiment Videos

Main Results:

  • The described method allows for the identification of minimum effective doses for multiple endpoints.
  • Stepwise procedures maintain statistical rigor while testing hypotheses sequentially.

Conclusions:

  • The proposed methodology provides a robust framework for minimum effective dose determination.
  • Stepwise testing offers a valid approach to control error rates in multi-endpoint studies.